May 15, 2023 PERSONAL AND CONFIDENTIAL Brian P. Kearney, PharmD Re: Separation Agreement and General Release of Claims Dear Brian:Separation Agreement and General Release of Claims • May 18th, 2023 • Pardes Biosciences, Inc. • Pharmaceutical preparations • California
This letter (this “Agreement”) confirms your separation from employment with Pardes Biosciences, Inc. (the “Company”) effective as of May 15, 2023 (the “Separation Date”) as a result of a reduction in force and not for Cause (as defined in Section 2(d) of the Executive Severance Plan, copy of which is attached hereto as Exhibit A (the “Executive Severance Plan)). The Company thanks you for your contributions to the Company and wishes you well in your future endeavors. Capitalized terms used in this Agreement and not otherwise defined shall have the meaning assigned to such term in the Executive Severance Plan.
CONSULTING AGREEMENTConsulting Agreement • May 18th, 2023 • Pardes Biosciences, Inc. • Pharmaceutical preparations • California
This CONSULTING AGREEMENT (this “Consulting Agreement”) is executed as of May 15, 2023 by and between Pardes Biosciences, Inc., a Delaware corporation (“Company”), and Brian P. Kearney, PharmD, a resident of the state of *** (“Consultant”) to be effective as of the first day following the Separation Date (as defined in the Separation Agreement (as defined below)) (the “Effective Date”) but contingent upon, and assuming that the Separation Agreement has become effective and not revoked. This Consulting Agreement is being entered into by the parties pursuant to that certain Separation Agreement and General Release of Claims dated as of May 15, 2023 (the “Separation Agreement”) and is Exhibit E to such Separation Agreement. Each capitalized term used herein and not otherwise defined shall have the meaning assigned to such term in the Separation Agreement.
